Company Filing History:
Years Active: 2023
Title: Innovations of Xiaotong Hu in Avian Influenza Treatment
Introduction
Xiaotong Hu is a notable inventor based in Hubei, China, recognized for his contributions to the field of medicine, particularly in the treatment and prevention of avian influenza virus infections. His innovative work has led to the development of effective compound preparations that enhance the immune response in infected animals.
Latest Patents
Xiaotong Hu holds two significant patents. The first patent focuses on the application of a compound bacterium preparation for treating or preventing avian influenza virus infection. This invention reveals that ATCC Accession No. 25527 can be utilized for treating animals infected by the H7N9 strain. When compounded with ATCC Accession No. 25526, the therapeutic effect is notably improved. This compound preparation not only regulates the immune response but also significantly mitigates weight loss and lung tissue injury caused by H7N9 influenza virus infection, thereby enhancing the survival rate of infected mice. The second patent involves the application of valine in preparing medicine for treating or preventing avian influenza virus infection. In a lethal mouse influenza infection model, valine has been shown to effectively improve weight loss, increase survival rates, and reduce the virus titer in the lung tissue of infected mice.
Career Highlights
Xiaotong Hu is affiliated with Huazhong Agricultural University, where he conducts research and develops innovative solutions for combating viral infections. His work is characterized by a strong focus on practical applications that can lead to significant improvements in animal health.
Collaborations
Xiaotong Hu collaborates with esteemed colleagues, including Meilin Jin and Qiang Zhang, to further advance research in the field of avian influenza treatment.
Conclusion
Xiaotong Hu's innovative contributions to the treatment of avian influenza highlight the importance of research in developing effective medical solutions. His patents demonstrate a commitment to improving animal health and combating viral infections through scientific advancements.